BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15610030)

  • 1. Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover.
    Winter M; Milne D; Dias S; Kulikov R; Knippschild U; Blattner C; Meek D
    Biochemistry; 2004 Dec; 43(51):16356-64. PubMed ID: 15610030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.
    Hjerrild M; Milne D; Dumaz N; Hay T; Issinger OG; Meek D
    Biochem J; 2001 Apr; 355(Pt 2):347-56. PubMed ID: 11284721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover.
    Dias SS; Hogan C; Ochocka AM; Meek DW
    FEBS Lett; 2009 Nov; 583(22):3543-8. PubMed ID: 19833129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2.
    Allende-Vega N; Dias S; Milne D; Meek D
    Mol Cell Biochem; 2005 Jun; 274(1-2):85-90. PubMed ID: 16335531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
    Lopez-Borges S; Lazo PA
    Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
    Kulikov R; Boehme KA; Blattner C
    Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel site of AKT-mediated phosphorylation in the human MDM2 onco-protein.
    Milne D; Kampanis P; Nicol S; Dias S; Campbell DG; Fuller-Pace F; Meek D
    FEBS Lett; 2004 Nov; 577(1-2):270-6. PubMed ID: 15527798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
    Dumaz N; Milne DM; Jardine LJ; Meek DW
    Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophosphorylation of Mdm2 augments p53 stability.
    Blattner C; Hay T; Meek DW; Lane DP
    Mol Cell Biol; 2002 Sep; 22(17):6170-82. PubMed ID: 12167711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
    Knippschild U; Milne DM; Campbell LE; DeMaggio AJ; Christenson E; Hoekstra MF; Meek DW
    Oncogene; 1997 Oct; 15(14):1727-36. PubMed ID: 9349507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export.
    Shinozaki T; Nota A; Taya Y; Okamoto K
    Oncogene; 2003 Dec; 22(55):8870-80. PubMed ID: 14654783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.
    Melnikova VO; Santamaria AB; Bolshakov SV; Ananthaswamy HN
    Oncogene; 2003 Sep; 22(38):5958-66. PubMed ID: 12955074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.
    Allende-Vega N; McKenzie L; Meek D
    Mol Cell Biochem; 2008 Sep; 316(1-2):99-106. PubMed ID: 18548200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
    Vega FM; Sevilla A; Lazo PA
    Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
    Burch LR; Scott M; Pohler E; Meek D; Hupp T
    J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
    Craig AL; Burch L; Vojtesek B; Mikutowska J; Thompson A; Hupp TR
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):133-41. PubMed ID: 10432310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.